Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil T Pfister

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Clinical Breast Cancer|July 16, 2020
The Influence of Histologic Grade on Outcomes of Elderly Women With Early Stage Breast Cancer Treated With Breast Conserving Surgery With or Without RadiotherapyChase E Escott, David Zaenger, Jeffrey M Switchencko, et al.
Advances in Radiation Oncology|May 7, 2025
National Institutes of Health Funding to Support Radiation Oncology Research: A Comparative Trend Analysis Over a Decade, 2011-2021Amir Razavi, Michael K Rooney, Clifton D Fuller, et al.
Cancer|April 24, 2019
Survival outcomes by high-risk human papillomavirus status in nonoropharyngeal head and neck squamous cell carcinomas: A propensity-scored analysis of the National Cancer Data BaseSibo Tian, Jeffrey M Switchenko, Jaymin Jhaveri, et al.
Cell|April 15, 2014
Mutant p53 drives pancreatic cancer metastasis through cell-autonomous PDGF receptor β signalingSusann Weissmueller, Eusebio Manchado, Michael Saborowski, et al.
Practical Radiation Oncology|October 7, 2019
Dosimetric Factors Related to Radiation Necrosis After 5-Fraction Radiosurgery for Patients With Resected Brain MetastasesDaniel G Tanenbaum, Zachary S Buchwald, Jaymin Jhaveri, et al.
Genes & Development|June 18, 2015
Mutant p53 cooperates with the SWI/SNF chromatin remodeling complex to regulate VEGFR2 in breast cancer cellsNeil T Pfister, Vitalay Fomin, Kausik Regunath, et al.
Oncogene|March 18, 2025
Correction: EZH2 has a non-catalytic and PRC2-independent role in stabilizing DDB2 to promote nucleotide excision repairAllyson E Koyen, Matthew Z Madden, Dongkyoo Park, et al.
Oncogene|May 28, 2020
EZH2 has a non-catalytic and PRC2-independent role in stabilizing DDB2 to promote nucleotide excision repairAllyson E Koyen, Matthew Z Madden, Dongkyoo Park, et al.
Nature Communications|October 14, 2024
Pre-operative stereotactic radiosurgery and peri-operative dexamethasone for resectable brain metastases: a two-arm pilot study evaluating clinical outcomes and immunological correlatesCaroline S Jansen, Meghana S Pagadala, Maria A Cardenas, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Clinical Breast Cancer|July 16, 2020
The Influence of Histologic Grade on Outcomes of Elderly Women With Early Stage Breast Cancer Treated With Breast Conserving Surgery With or Without RadiotherapyChase E Escott, David Zaenger, Jeffrey M Switchencko, et al.
Advances in Radiation Oncology|May 7, 2025
National Institutes of Health Funding to Support Radiation Oncology Research: A Comparative Trend Analysis Over a Decade, 2011-2021Amir Razavi, Michael K Rooney, Clifton D Fuller, et al.
Cancer|April 24, 2019
Survival outcomes by high-risk human papillomavirus status in nonoropharyngeal head and neck squamous cell carcinomas: A propensity-scored analysis of the National Cancer Data BaseSibo Tian, Jeffrey M Switchenko, Jaymin Jhaveri, et al.
Cell|April 15, 2014
Mutant p53 drives pancreatic cancer metastasis through cell-autonomous PDGF receptor β signalingSusann Weissmueller, Eusebio Manchado, Michael Saborowski, et al.
Practical Radiation Oncology|October 7, 2019
Dosimetric Factors Related to Radiation Necrosis After 5-Fraction Radiosurgery for Patients With Resected Brain MetastasesDaniel G Tanenbaum, Zachary S Buchwald, Jaymin Jhaveri, et al.
Genes & Development|June 18, 2015
Mutant p53 cooperates with the SWI/SNF chromatin remodeling complex to regulate VEGFR2 in breast cancer cellsNeil T Pfister, Vitalay Fomin, Kausik Regunath, et al.
Oncogene|March 18, 2025
Correction: EZH2 has a non-catalytic and PRC2-independent role in stabilizing DDB2 to promote nucleotide excision repairAllyson E Koyen, Matthew Z Madden, Dongkyoo Park, et al.
Oncogene|May 28, 2020
EZH2 has a non-catalytic and PRC2-independent role in stabilizing DDB2 to promote nucleotide excision repairAllyson E Koyen, Matthew Z Madden, Dongkyoo Park, et al.
Nature Communications|October 14, 2024
Pre-operative stereotactic radiosurgery and peri-operative dexamethasone for resectable brain metastases: a two-arm pilot study evaluating clinical outcomes and immunological correlatesCaroline S Jansen, Meghana S Pagadala, Maria A Cardenas, et al.
Pageof 2